{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T04:28:52Z","timestamp":1730348932706,"version":"3.28.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,30]]},"DOI":"10.7759\/cureus.72698","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:08:51Z","timestamp":1730300931000},"source":"Crossref","is-referenced-by-count":0,"title":["Secukinumab-Aggravated Disseminated Discoid Lupus Erythematosus Misdiagnosed as Psoriasis"],"prefix":"10.7759","author":[{"given":"Binrong","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_207_19","article-title":"Dermoscopic criteria of discoid lupus erythematosus: an observational cross-sectional study of 28 patients","volume":"88","author":"Fathy H","year":"2022","unstructured":"Fathy H, Ghanim BM, Refat S, Awad A. Dermoscopic criteria of discoid lupus erythematosus: an observational cross-sectional study of 28 patients. Indian J Dermatol Venereol Leprol. 2022, 88:360-6. 10.25259\/IJDVL_207_19","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref2","article-title":"Comparison of guidelines for the use of interleukin-17 inhibitors for psoriasis in the United States, Britain, and Europe: a critical appraisal and comprehensive review","volume":"14","author":"Kearns DG","year":"2021","unstructured":"Kearns DG, Uppal S, Chat VS, Wu JJ. Comparison of guidelines for the use of interleukin-17 inhibitors for psoriasis in the United States, Britain, and Europe: a critical appraisal and comprehensive review. Journal of Clinical and Aesthetic Dermatology. 2021, 14:55-9.","journal-title":"Journal of Clinical and Aesthetic Dermatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0272-0","article-title":"Cutaneous lupus erythematosus: new insights into pathogenesis and\u00a0therapeutic strategies","volume":"15","author":"Wenzel J","year":"2019","unstructured":"Wenzel J. Cutaneous lupus erythematosus: new insights into pathogenesis and\u00a0therapeutic strategies. Nat Rev Rheumatol. 2019, 15:519-32. 10.1038\/s41584-019-0272-0","journal-title":"Nat Rev Rheumatol"},{"key":"ref4","article-title":"Lupus erythematosus, chronic discoid or chronic disseminated","volume":"66","author":"Jones EH","year":"1952","unstructured":"Jones EH. Lupus erythematosus, chronic discoid or chronic disseminated. AMA Archives of Dermatology and Syphilology. 1952, 66:541-2.","journal-title":"AMA Archives of Dermatology and Syphilology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2022.09.005","article-title":"Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects","volume":"98","author":"Vale EC","year":"2023","unstructured":"Vale EC, Garcia LC. Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects. An Bras Dermatol. 2023, 98:355-72. 10.1016\/j.abd.2022.09.005","journal-title":"An Bras Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/09612033221095692","article-title":"Aggravation of discoid lupus erythematosus in a patient with psoriasis and psoriatic arthritis during treatment of secukinumab: a case report and review of literature","volume":"31","author":"Hsieh CY","year":"2022","unstructured":"Hsieh CY, Tsai TF. Aggravation of discoid lupus erythematosus in a patient with psoriasis and psoriatic arthritis during treatment of secukinumab: a case report and review of literature. Lupus. 2022, 31:891-4. 10.1177\/09612033221095692","journal-title":"Lupus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.02.013","article-title":"Secukinumab-induced chronic discoid lupus erythematosus","volume":"6","author":"Chatzimichail G","year":"2020","unstructured":"Chatzimichail G, Zillikens D, Tha\u00e7i D. Secukinumab-induced chronic discoid lupus erythematosus. JAAD Case Rep. 2020, 6:362-4. 10.1016\/j.jdcr.2020.02.013","journal-title":"JAAD Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071485","article-title":"Pathogenesis of paradoxical reactions associated with targeted biologic agents for inflammatory skin diseases","volume":"10","author":"Miyagawa F","year":"2022","unstructured":"Miyagawa F. Pathogenesis of paradoxical reactions associated with targeted biologic agents for inflammatory skin diseases. Biomedicines. 2022, 10:1485. 10.3390\/biomedicines10071485","journal-title":"Biomedicines"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead318","article-title":"The predictors of paradoxical reactions, especially psoriasis, to biologic therapy-findings from the TReasure database: a 5-year follow-up study","volume":"62","author":"Yagiz B","year":"2023","unstructured":"Yagiz B, Lermi N, Coskun BN, et al.. The predictors of paradoxical reactions, especially psoriasis, to biologic therapy-findings from the TReasure database: a 5-year follow-up study. Rheumatology (Oxford). 2023, 62:3962-7. 10.1093\/rheumatology\/kead318","journal-title":"Rheumatology (Oxford)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000479475","article-title":"Paradoxical reactions: anti-tumor necrosis factor alpha agents, ustekinumab, secukinumab, ixekizumab, and others","volume":"53","author":"Puig L","year":"2018","unstructured":"Puig L. Paradoxical reactions: anti-tumor necrosis factor alpha agents, ustekinumab, secukinumab, ixekizumab, and others. Curr Probl Dermatol. 2018, 53:49-63. 10.1159\/000479475","journal-title":"Curr Probl Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.03944.x","article-title":"Interleukin-17 and systemic lupus erythematosus: current concepts","volume":"157","author":"Nalbandian A","year":"2009","unstructured":"Nalbandian A, Crisp\u00edn JC, Tsokos GC. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol. 2009, 157:209-15. 10.1111\/j.1365-2249.2009.03944.x","journal-title":"Clin Exp Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312441982","article-title":"Response to ustekinumab in a patient with both severe psoriasis and hypertrophic cutaneous lupus","volume":"21","author":"Winchester D","year":"2012","unstructured":"Winchester D, Duffin KC, Hansen C. Response to ustekinumab in a patient with both severe psoriasis and hypertrophic cutaneous lupus. Lupus. 2012, 21:1007-10. 10.1177\/0961203312441982","journal-title":"Lupus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_961_18","article-title":"Exacerbation of systemic lupus erythematosus in a patient with concomitant chronic plaque psoriasis treated with ustekinumab","volume":"86","author":"Goh SW","year":"2020","unstructured":"Goh SW, Jamil A, Nor NM, Cader RA, Shaharir SS. Exacerbation of systemic lupus erythematosus in a patient with concomitant chronic plaque psoriasis treated with ustekinumab. Indian J Dermatol Venereol Leprol. 2020, 86:68-70. 10.4103\/ijdvl.IJDVL_961_18","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/282191-secukinumab-aggravated-disseminated-discoid-lupus-erythematosus-misdiagnosed-as-psoriasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:08:52Z","timestamp":1730300932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/282191-secukinumab-aggravated-disseminated-discoid-lupus-erythematosus-misdiagnosed-as-psoriasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.72698","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,30]]}}}